Drug Discovery and Development Analysis & Statistics, February 2013 (p3)

Reperfusion Injury Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Reperfusion Injury Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Reperfusion Injury Global Clinical Trials Review, H1, 2013" provides data on the Reperfusion Injury ...

Industries : Drug Discovery and Development
Countries : World

Ulcers Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Ulcers Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Ulcers Global Clinical Trials Review, H1, 2013" provides data on the Ulcers clinical trial scenario. This report ...

Industries : Drug Discovery and Development
Countries : World

Deglutition Disorders Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Deglutition Disorders Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Deglutition Disorders Global Clinical Trials Review, H1, 2013" provides data on the Deglutition ...

Industries : Drug Discovery and Development
Countries : World

Hyperalgesia Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Hyperalgesia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial ...

Industries : Drug Discovery and Development
Countries : United States, World

Aortic Aneurysm Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Aortic Aneurysm Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Aortic Aneurysm Global Clinical Trials Review, H1, 2013" provides data on the Aortic Aneurysm clinical ...

Industries : Drug Discovery and Development
Countries : World

Strabismus Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Strabismus Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Strabismus Global Clinical Trials Review, H1, 2013" provides data on the Strabismus clinical trial scenario. ...

Industries : Drug Discovery and Development
Countries : World

Alopecia Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Alopecia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Alopecia Global Clinical Trials Review, H1, 2013" provides data on the Alopecia clinical trial scenario. ...

Industries : Drug Discovery and Development
Countries : World, United States

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013" provides data on the Hidradenitis ...

Industries : Drug Discovery and Development
Countries : United States, World

Hypotension Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Hypotension Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Hypotension Global Clinical Trials Review, H1, 2013" provides data on the Hypotension clinical trial scenario. ...

Industries : Drug Discovery and Development
Countries : World

Gestational Diabetes Global Clinical Trials Review, H1, 2013

$ 2 500
Industry report
February 2013
by Global Data

Gestational Diabetes Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Gestational Diabetes Global Clinical Trials Review, H1, 2013" provides data on the Gestational ...

Industries : Drug Discovery and Development
Countries : World

World Pharmaceutical: Community-Acquired Infections - Pipeline Review, H1 2012

$ 2 000
Industry report
February 2013
by Global Markets Direct

This report provides information on the therapeutic development for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

Industries : Drug Discovery and Development
Countries : World

World Therapy: Fever - Pipeline Review, H1 2012

$ 2 000
Industry report
February 2013
by Global Markets Direct

This report provides information on the therapeutic development for Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

Industries : Drug Discovery and Development
Countries : World, United States

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade%s Disease) - Pipeline Review, H1 2013

$ 2 000
Industry report
February 2013
by Global Markets Direct

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, ...

Industries : Drug Discovery and Development
Countries : World

World Drug and Medication: Mild Cognitive Impairment - Pipeline Review, H1 2012

$ 2 000
Company report
April 2013
by Global Markets Direct

This report provides data on the therapeutic development for Mild Cognitive Impairment, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Industries : Drug Discovery and Development
Countries : World

Global Proteomics Market 2012-2016

$ 2 000
Industry report
April 2013
by Infiniti Research Limited

TechNavio's analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand ...

Industries : Drug Discovery and Development
Countries : World

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2013

$ 2 000
Industry report
February 2013
by Global Markets Direct

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2013', provides an overview of the indication's ...

Industries : Drug Discovery and Development
Countries : China, World

IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

The IL-3 signaling pathway activates the JAK/STAT, MAPK and PI 3-kinase signaling modules. There are today 172 companies plus partners developing 222 IL-3 pathway targeting drugs in 789 developmental projects ...

Industries : Drug Discovery and Development

GnRH Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. There are ...

Industries : Drug Discovery and Development

IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

The IL-2 signaling pathway activates the Ras/MAPK, JAK/Stat and PI 3-kinase/Akt signaling modules. There are today 229 companies plus partners developing 329 IL-2 pathway targeting drugs in 1082 developmental ...

Industries : Drug Discovery and Development

IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

The IL-4 signaling pathway stimulates the JAK/STAT and MAPK signaling modules. There are today 135 companies plus partners developing 179 IL-4 pathway targeting drugs in 556 developmental projects in cancer. ...

Industries : Drug Discovery and Development

Gap Junctions in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Gap junctions contain intercellular channels that allow direct communication between the cytosolic compartments of adjacent cells. Each gap junction channel is formed by docking of two 'hemichannels', ...

Industries : Drug Discovery and Development

TSH Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Human thyroid stimulating hormone (TSH) exerts its action through various signaling cascades such as cAMP cascade and the phospholipase C beta-mediated inositol phosphate generation. Further, it will give ...

Industries : Drug Discovery and Development

IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

The IL-5 singaling pathway activates the JAK/STAT and Raf/MAPK signaling modules. There are today 109 companies plus partners developing 134 IL-5 pathway targeting drugs in 514 developmental projects in ...

Industries : Drug Discovery and Development

Angiogenesis in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

There are today 256 companies plus partners developing 263 angiogenesis drugs in 1107 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs ...

Industries : Drug Discovery and Development

Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

The Alpha6 Beta4 Integrin signaling pathway activates the PI 3-kinase/Akt, MAPK/NFkB and SMAD signaling modules. There are today 228 companies plus partners developing 321 Alpha6Beta4 integrin pathway ...

Industries : Drug Discovery and Development

Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways ...

Industries : Drug Discovery and Development

FSH Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Follicle stimulating hormone (FSH) binds to FSH-receptor which is coupled to Gs protein that in turn activates cAMP dependent protein kinases (PKA) and thus triggers FSH signaling which continues furthe ...

Industries : Drug Discovery and Development

IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

The IL-6 signaling pathway activates the Jak/STAT, Ras/Raf/MAPK and PI 3-kinase signaling modules. There are today 243 companies plus partners developing 321 IL-6 pathway targeting drugs in 1010 developmental ...

Industries : Drug Discovery and Development

Adherens Junction Targeting in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Cell-cell adherens junctions, the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. There are ...

Industries : Drug Discovery and Development

Apoptosis in Oncology Drug Pipeline Update 2013

$ 2 249
Industry report
April 2013
by Bioseeker

Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis ...

Industries : Drug Discovery and Development

Armenia Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Armenia

Congo Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2007 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Congo, Democratic Republic Of

Burkina Faso Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Burkina Faso

Afghanistan Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2007 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Afghanistan

Botswana Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Botswana

Number Of Approvals Of Registration-drug_clinical Trials Of Imported Drug-china-annual, In Unit (units)

$ 250
Industry data
May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

Industries : Drug Discovery and Development

Number Of Approvals Of Registration-drug_imported Drug Registration-china-annual, In Unit (units)

$ 250
Industry data
May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

Industries : Drug Discovery and Development

Australia Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2006 To 2011
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Australia

Argentina Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Argentina

Bangladesh Total Clinical Trials

$ 250
Industry data
January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Industries : Drug Discovery and Development
Countries : Bangladesh